scPharmaceuticals Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
scPharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2023.
  • scPharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$17.1M, a 20.7% decline year-over-year.
  • scPharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$60.6M, a 35.4% decline year-over-year.
  • scPharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$54.8M, a 48.8% decline from 2022.
  • scPharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$36.8M, a 31.4% decline from 2021.
  • scPharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$28M, a 13% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$54.8M -$18M -48.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 -$36.8M -$8.8M -31.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 -$28M +$4.18M +13% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 -$32.2M +$787K +2.39% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 -$33M -$3.55M -12.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
2018 -$29.4M -$5.63M -23.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-24
2017 -$23.8M +$560K +2.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-21
2016 -$24.4M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.